Anti-lymphangiogenic properties of mTOR inhibitors in head and neck squamous cell carcinoma experimental models

被引：0
|
作者：
Oleksandr Ekshyyan
Tara N Moore-Medlin
Matthew C Raley
Kunal Sonavane
Xiaohua Rong
Michael A Brodt
Fleurette Abreo
Jonathan Steven Alexander
Cherie-Ann O Nathan
机构：
[1] Louisiana State University Health Sciences Center,Department of Otolaryngology/Head and Neck Surgery
[2] Feist-Weiller Cancer Center,undefined
[3] LSUHSC,undefined
[4] Department of Pathology,undefined
[5] LSUHSC,undefined
[6] Department of Cellular and Molecular Physiology,undefined
[7] LSUHSC,undefined
来源：
BMC Cancer | / 13卷
关键词：
Head and neck squamous cell carcinoma; Rapamycin; mTOR inhibitors; mTOR; VEGFR-3; VEGFR-2; Lymph node metastasis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Anti-lymphangiogenic properties of mTOR inhibitors in head and neck squamous cell carcinoma experimental models
    Ekshyyan, Oleksandr
    Moore-Medlin, Tara N.
    Raley, Matthew C.
    Sonavane, Kunal
    Rong, Xiaohua
    Brodt, Michael A.
    Abreo, Fleurette
    Alexander, Jonathan Steven
    Nathan, Cherie-Ann O.
    BMC CANCER, 2013, 13
  • [2] mTOR Inhibitors and its Role in the Treatment of Head and Neck Squamous Cell Carcinoma
    Nguyen, Shaun A.
    Walker, David
    Gillespie, M. Boyd
    Gutkind, J. Silvio
    Day, Terry A.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2012, 13 (01) : 71 - 81
  • [3] mTOR inhibitors show promising in vitro activity in bladder cancer and head and neck squamous cell carcinoma
    Schedel, Fiona
    Pries, Ralph
    Thode, Beate
    Wollmann, Brigitte
    Wulff, Sandra
    Jocham, Dieter
    Wollenberg, Barbara
    Kausch, Ingo
    ONCOLOGY REPORTS, 2011, 25 (03) : 763 - 768
  • [4] mTOR Inhibitors and its Role in the Treatment of Head and Neck Squamous Cell Carcinoma
    Shaun A. Nguyen
    David Walker
    M. Boyd Gillespie
    J. Silvio Gutkind
    Terry A. Day
    Current Treatment Options in Oncology, 2012, 13 : 71 - 81
  • [5] Animal models of head and neck squamous cell carcinoma
    Supsavhad, Wachiraphan
    Dirksen, Wessel P.
    Martin, Chelsea K.
    Rosol, Thomas J.
    VETERINARY JOURNAL, 2016, 210 : 7 - 16
  • [6] Morphoproteomic and pharmacoproteomic rationale for mTOR effectors as therapeutic targets in head and neck squamous cell carcinoma
    Brown, Robert E.
    Zhang, Ping L.
    Lun, Mingyne
    Zhu, Shaobo
    Pellitteri, Phillip K.
    Law, Amy
    Wood, G. Craig
    Kennedy, Thomas L.
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2006, 36 (03) : 273 - 282
  • [7] Targeting mTOR by CZ415 Inhibits Head and Neck Squamous Cell Carcinoma Cells
    Xie, Jing
    Li, Quan
    Ding, Xi
    Gao, Yunyun
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 46 (02) : 676 - 686
  • [8] mTOR inhibitor use in head and neck squamous cell carcinoma: A meta-analysis on survival, tumor response, and toxicity
    Patel, Jaimin
    Nguyen, Shaun A.
    Ogretmen, Besim
    Gutkind, Jorge S.
    Nathan, Cherie-Ann
    Day, Terry
    LARYNGOSCOPE INVESTIGATIVE OTOLARYNGOLOGY, 2020, 5 (02): : 243 - 255
  • [9] Targeting mTOR-CCL20 Signaling May Improve Response to Docetaxel in Head and Neck Squamous Cell Carcinoma
    Chou, Ming-Huei
    Chuang, Hui-Ching
    Lin, Yu-Tsai
    Tsai, Ming-Hsien
    Kao, Ying-Hsien
    Lin, I-Chun
    Huang, Tai-Lin
    Fang, Fu-Min
    Chien, Chih-Yen
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (06) : 1 - 15
  • [10] Models of head and neck squamous cell carcinoma using bioengineering approaches
    Bonartsev, Anton P.
    Lei, Bo
    Kholina, Margarita S.
    Menshikh, Ksenia A.
    Svyatoslavov, Dmitriy S.
    Samoylova, Svetlana I.
    Sinelnikov, Mikhail Y.
    Voinova, Vera V.
    Shaitan, Konstantin V.
    Kirpichnikov, Mikhail P.
    Reshetov, Igor V.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022, 175
12345